CME Group Enters Licensing Agreement With Morningstar to Offer Derivatives Products

Dow Jones
06/11

By Kelly Cloonan

 

CME Group and Morningstar entered a multi-year licensing agreement, allowing the derivatives marketplace to offer products based on the investment insight provider's equity index benchmarks.

Under the agreement, CME Group will sell trading contracts based on the Morningstar Market Indexes, including ones covering U.S. total market, along with large, mid and small cap stocks, the companies said Wednesday.

The deal comes after Morningstar acquired the Center for Research in Security Prices, or CRSP, a provider of historical stock-market data and indexes, earlier this year. The company said it is currently rebranding CRSP to Morningstar Market Indexes.

CME Group said the move aims to enable its clients to use derivatives based on indexes that underpin more than $3 trillion in linked assets. It is also expected to provide clients with a better framework to navigate market volatility, the company said.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

June 10, 2026 17:32 ET (21:32 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10